二维剪切波弹性成像、瞬时弹性成像与MR弹性成像诊断非酒精性脂肪性肝病肝纤维化的比较
该研究前瞻性纳入62例经活检证实非酒精性脂肪性肝病的成人,比较二维剪切波弹性成像、瞬时弹性成像与MR弹性成像测量肝硬度的诊断准确性。MR弹性成像诊断晚期纤维化的AUC最高(0.95),三种方法对显著纤维化和晚期纤维化的诊断准确性两两比较均无统计学显著差异。
要点
- MR弹性成像诊断晚期纤维化AUC 0.95,二维剪切波弹性成像0.89,瞬时弹性成像0.86。
- 三种方法对显著纤维化和晚期纤维化的诊断准确性两两比较均无统计学显著差异。
- 二维剪切波弹性成像、瞬时弹性成像与MR弹性成像对晚期纤维化诊断准确性可比且很好至极好。
核心结论
- 对经活检证实非酒精性脂肪性肝病患者,二维剪切波弹性成像、MR弹性成像与瞬时弹性成像对晚期纤维化诊断准确性可比且很好至极好,对显著纤维化诊断准确性可比但较低。
研究设计与样本
- 前瞻性纳入62例成人(平均年龄50±13岁,58%为女性,体重指数35±7),均经活检证实为非酒精性脂肪性肝病。
- 二维剪切波弹性成像、MR弹性成像与瞬时弹性成像在肝活检后平均105±86天完成。
- 以Metavir肝纤维化评分F2-F4为显著纤维化、F3-F4为晚期纤维化作为结局指标,计算肝硬度值(千帕)的AUROC及95%CI,并用DeLong检验进行两两比较,统计学显著性设为p<0.05。
诊断标准与关键数值
- 二维剪切波弹性成像诊断显著纤维化(F2-F4)的AUROC为0.80(95%CI 0.67-0.92),诊断晚期纤维化(F3-F4)的AUROC为0.89(95%CI 0.80-0.98)。
- 瞬时弹性成像诊断显著纤维化的AUROC为0.77(95%CI 0.64-0.89),诊断晚期纤维化的AUROC为0.86(95%CI 0.77-0.95)。
- MR弹性成像诊断显著纤维化的AUROC为0.85(95%CI 0.74-0.95),诊断晚期纤维化的AUROC为0.95(95%CI 0.89-1.00)。
- 显著纤维化两两比较:二维剪切波弹性成像 vs MR弹性成像 p=0.431,二维剪切波弹性成像 vs 瞬时弹性成像 p=0.317,MR弹性成像 vs 瞬时弹性成像 p=0.052。
- 晚期纤维化两两比较:二维剪切波弹性成像 vs MR弹性成像 p=0.348,二维剪切波弹性成像 vs 瞬时弹性成像 p=0.293,MR弹性成像 vs 瞬时弹性成像 p=0.059。
临床应用与阅片要点
- 在经活检证实的非酒精性脂肪性肝病患者中,二维剪切波弹性成像、瞬时弹性成像与MR弹性成像对晚期纤维化诊断准确性可比且很好至极好。
- 三种方法对显著纤维化的诊断准确性可比但低于对晚期纤维化的诊断准确性。
局限性
- 62例受试者中,二维剪切波弹性成像获得有效肝硬度值57例,瞬时弹性成像59例,MR弹性成像59例,三种方法均获得有效值者54例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The aim of the present study was to compare the diagnostic accuracy of liver stiffness measurements (LSMs) obtained using MR elastography (MRE), transient elastography (TE), and 2D shear wave elastography (SWE) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD). SUBJECTS AND METHODS. We prospectively enrolled 62 adult subjects (mean age [± SD], 50 ± 13 years; 58% women; body mass index [weight in kilograms divided by the square of height in meters], 35 ± 7). Two-dimensional SWE, MRE, and TE were performed at a mean of 105 ± 86 days after liver biopsy. The area under the ROC curve (AUROC) values and 95% CIs for the corresponding LSMs (expressed in kilopascals) were calculated, with significant fibrosis (Metavir liver fibrosis score, F2-F4) and advanced fibrosis (F3-F4) used as outcome measures. Pairwise comparisons of AUROC values were conducted using the DeLong test. Statistical significance was set at p < 0.05. RESULTS. For the 62 subjects, valid LSMs were obtained for 57 subjects with the use of 2D SWE, for 59 subjects with TE, for 59 subjects with MRE, and for 54 subjects with all three modalities combined. The AUROC values (95% CIs) of 2D SWE, TE, and MRE for the diagnosis of significant fibrosis were 0.80 (0.67-0.92), 0.77 (0.64-0.89), and 0.85 (0.74-0.95), respectively. The AUROC values (95% CIs) of 2D SWE, TE, and MRE for the diagnosis of advanced fibrosis were 0.89 (0.80-0.98), 0.86 (0.77-0.95), and 0.95 (0.89-1.00), respectively. Pairwise comparisons revealed similar diagnostic accuracy for significant fibrosis (2D SWE vs MRE, p = 0.431; 2D SWE vs TE, p = 0.317; and MRE vs TE, p = 0.052) and advanced fibrosis (2D SWE vs MRE, p = 0.348; 2D SWE vs TE, p = 0.293; and MRE vs TE, p = 0.059). CONCLUSION. For patients with biopsy-proven NAFLD, 2D SWE, MRE and TE exhibited comparable and very good to excellent diagnostic accuracy for advanced fibrosis and comparable but lower accuracy for significant fibrosis.
引用
- Furlan A, Tublin ME, Yu L, et al. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. AJR Am J Roentgenol. 2019. PMID: 31714842. doi:10.2214/AJR.19.21267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。